FDA Inspection 1166787 — Royal Canin USA, Inc.
The FDA completed an inspection of Royal Canin USA, Inc. on April 4, 2022 in Saint Charles, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 4, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Saint Charles, MO (United States)
Additional Details
FSVP